Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group N9831 adjuvant trastuzumab trial

Edith A. Perez, E. Aubrey Thompson, Karla V. Ballman, S. Keith Anderson, Yan W. Asmann, Krishna R. Kalari, Jeanette E. Eckel-Passow, Amylou C. Dueck, Kathleen S. Tenner, Jin Jen, Jian Bing Fan, Xochiquetzal J. Geiger, Ann E. McCullough, Beiyun Chen, Robert B. Jenkins, George W. Sledge, Eric P. Winer, Julie R. Gralow, Monica M. Reinholz

Research output: Contribution to journalArticlepeer-review

140 Scopus citations

Fingerprint

Dive into the research topics of 'Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group N9831 adjuvant trastuzumab trial'. Together they form a unique fingerprint.

Medicine & Life Sciences